• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Imatron revenues soar 147%

Article

Ultrafast CT developer Imatron is beginningto experience increased demand for its high-priced CT technology.The South San Francisco, CA, vendor reported last month that revenuesskyrocketed 147% for the second quarter (end-June). Imatron recorded

Ultrafast CT developer Imatron is beginningto experience increased demand for its high-priced CT technology.The South San Francisco, CA, vendor reported last month that revenuesskyrocketed 147% for the second quarter (end-June).

Imatron recorded revenues of $7.9 million for the quarter,a marked improvement over the $3.2 million reported in the sameperiod last year. Income was also up sharply. Imatron recordednet income of $447,000, compared to a net loss of $2.7 millionin the second quarter of 1993.

Imatron shipped four Ultrafast CT scanners during the quarterand achieved several other milestones in its technology developmentprojects, according to president and CEO Lewis Meyer.

Imatron has a CT development agreement with Siemens, whichmarkets the Imatron scanner as Evolution EBT (electron-beam tomography).Imatron also operates HeartScan Imaging, which provides UltrafastCT coronary artery scanning in company-owned clinics (SCAN 4/6/94).

Recent Videos
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Can 18F-Floutufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.